Veterans Pharmaceuticals Applies for DEA Nod on Controlled Drug Imports
Published Date: 8/11/2025
Notice
Summary
Veterans Pharmaceuticals, Inc. wants to get official approval to bring in certain controlled substances. This means they’ll be able to import these drugs legally, which could affect how these medicines reach the market. Keep an eye out for updates on their registration status and any related deadlines or fees.
No Economic Impacts Identified for this Document
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-15624, Amendment to 3,4-MDP-2-P Methyl Glycidic Acid, a List I Chemical
The Drug Enforcement Administration is proposing to modify the listing of the list I chemical 3,4-MDP-2-P methyl glycidic acid (also known as PMK glycidic acid) to include esters of 3,4-MDP-2-P methyl glycidic acid, not listed elsewhere in the Controlled Substances Act (CSA), as list I chemicals under the CSA. The current listing of 3,4- MDP-2-P methyl glycidic acid includes its salts, optical and geometric isomers, and salts of isomers. DEA proposes the new listing to read as follows: 3,4-MDP-2-P methyl glycidic acid (PMK glycidic acid) and its esters, not listed elsewhere in the CSA, its optical and geometric isomers, its salts, salts of its optical and geometric isomers, salts of its esters, not listed elsewhere in the CSA, and any combination thereof, whenever the existence of such is possible.
2026-15328, Joan Rubinger, N.P.; Decision and Order
2026-15201, Gene M. Koop, D.D.S.; Decision and Order
2026-15199, Kerri Zavota, DVM; Decision and Order
Previous / Next Documents
Previous: 2025-15152, Privacy Act of 1974; Matching Program
The Social Security Administration (SSA) is teaming up with the IRS to share tax info to make sure Medicare Part B and D premiums are set just right. This new matching program helps adjust subsidies and premium increases accurately, so folks get fair billing. It affects anyone on Medicare and kicks in soon, with no extra cost to you.
Next: 2025-15154, Applications for New Awards; Assistance for Arts Education Program
The Department of Education is inviting schools and organizations to apply for new grants in 2025 to support arts education programs. This means more money and opportunities to bring music, dance, theater, and visual arts into classrooms. If you’re passionate about arts in schools, now’s the time to get your application ready and help inspire the next generation of artists!